None listed
Conditions
Brief summary
This study evaluates an innovative therapeutic intervention to reduce psychological distress and improve quality of life for men diagnosed with advanced prostate cancer. Who is it for? This study is for men who have been diagnosed with advanced prostate cancer in Queensland, New South Wales, Victoria and Western Australia. Trial details In this study participants are randomly (by chance) divided into two groups. One group will receive patient education, i.e. currently available resource and support materials. The other group will receive a telephone delivered mindfulness-based cognitive therapy group intervention. This intervention includes group therapy phone calls for participants led by trained health professionals and daily meditation practice. The duration of this intervention is 8 weeks. Participants will complete questionnaires at 3, 6 and 9 months after enrolling in the study to evaluate their psychological well-being and quality of life.
Interventions
The mindfulness-based cognitive therapy (MBCT) group intervention will include tele-based group cognitive therapy and home practice. The group therapy sessions will be conducted weekly over 8 weeks and will each be between one and one and a half hours in length. Each group will contain seven men, and be facilitated by health professionals with experience in oncology, professional training in MBCT and training in the telephone delivery of interventions. Participants in the intervention will also
The mindfulness-based cognitive therapy (MBCT) group intervention will include tele-based group cognitive therapy and home practice. The group therapy sessions will be conducted weekly over 8 weeks and will each be between one and one and a half hours in length. Each group will contain seven men, and be facilitated by health professionals with experience in oncology, professional training in MBCT and training in the telephone delivery of interventions. Participants in the intervention will also be provided with a workbook summarising each weekly session and including interactive worksheets to keep group discussions on task; self-help materials; and a meditation CD. Participants who are randomised to the intervention condition will be mailed the intervention materials and allocated to a therapy group immediately after randomisation.
Sponsors
Cancer Council Queensland
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients must: (1) have proven metastatic prostate cancer or castration resistant biochemical progression; (2) be able to read and speak English; (3) have no previous history of head injury, dementia or psychiatric illness; (4) have no other concurrent cancer; (5) have phone access.
Exclusion criteria
Participants must not: (1) have localised prostate cancer or biochemical progression of their prostate cancer only; (2) have previous head injury or dementia; (3) be unable to read and write English; (4) be undergoing treatment for another cancer.
Outcome results
None listed